Introduction {#s1}
============

The gradual and irreversible decline in cellular homeostasis that accompanies aging can be delayed by using several methods. For example, lifespan of various model organisms can be extended genetically via perturbation of nutrient sensing, pharmacologically by rapamycin treatment, or nutritionally by dietary restriction ([@bib5]; [@bib16]). Up-regulation of stress response and repair pathways, often linked to conditions of mild stress or hormesis ([@bib47]), may also promote longevity. On the other hand, the specific molecular processes that accompany the delay in the aging process are not well understood.

It is often discussed that aging involves damage accumulation, therein an increase in DNA mutations, errors in protein synthesis, unwanted posttranslational modifications, metabolite by-products and many other damage forms contribute to the aging process ([@bib46]). The source of damage is frequently linked to metabolic activities, such as those that produce reactive oxygen species and increase oxidative modifications ([@bib23]). Damage may also be driven by global metabolic infidelity and engage nearly all biological processes involving synthesis and breakdown of cellular components ([@bib23]; [@bib19]). The exact mechanisms responsible for tolerance against molecular damage are not fully understood, but studies identified robust transcriptional remodeling that accompanies the aging process ([@bib30]; [@bib56]; [@bib45]; [@bib35]; [@bib13]; [@bib50]). How such responses are linked to cumulative damage is not known, since gene expression changes may not reflect immediate biological activities and metabolic fluxes. Another complication in such analyses is that individual damage types (e.g., mutations, lipofuscin accumulation, oxidative modifications) vary across conditions and among species ([@bib46]; [@bib15]; [@bib12]; [@bib21]). The patterns of damage accumulation are also incompletely defined since many of the previous studies did not analyze samples representing very old ages ([@bib1]; [@bib15]; [@bib21]). Yet, insights into the properties of cumulative damage are required for comprehensive assessment of the activity-driven damage models of aging. Addressing these critical questions requires examination of damage composition and heterogeneity and the mortality-associated trends in the accumulation of numerous damage forms under both control and lifespan extending conditions. Aside from damage forms, it is unclear how cellular components generally change as a function of age, whether their patterns mimic the transcriptional responses and whether possible changes in their levels can have causal roles in the aging process.

Metabolite profiling is an emerging method that aims to characterize a large number of small molecules in biological systems and identify proximal markers of biological activity ([@bib26]; [@bib42]; [@bib25]). Recently, metabolite profiling was used to explore metabolic signatures of aging in young vs old mice ([@bib20]; [@bib52]) using a set of markers, thereby confirming that aging is associated with alterations in nutrient sensing, lipid and amino acid metabolism, and redox homeostasis. Another strength of metabolite profiling lies in nontargeted profiling, which enables analysis of thousands of small molecules, albeit of unknown chemical properties. Nontargeted profiling may also be used to characterize patterns of molecular damage by following changes in metabolite diversity. For example, damaged molecular species are expected to exhibit age-associated mass shifts, which may be represented by an increase in metabolite diversity, potentially offering a larger repertoire of damage forms than analyzed previously. By following global changes in metabolome remodeling in response to aging and lifespan-extending interventions, the nontargeted profiling may also lead to the identification of small molecule regulators of the aging process.

Here, we utilized nontargeted, liquid chromatography mass spectrometry (LC-MS)-based metabolite profiling to explore age-associated patterns in metabolite diversity and biological activity in *Drosophila* males maintained on diets that support different lifespan. We discover that metabolite diversity shows a robust age-associated increase. In contrast, known metabolites as well as many metabolites that are detected at all ages show bi-directional trends during aging: they fall predominantly into increasing and decreasing age-associated clusters. Interestingly, older cohorts feature deceleration in both the rise in metabolite diversity and overall cellular activity. Together, these data suggest that changes reflecting biological activity are linked to the display of metabolome diversity, which is reflected in the appearance of new small molecule species. We followed metabolites implicated in certain forms of damage and found their levels to be higher in long-living flies. These data further implicate a heterogeneous nature of damage whose effect on survivorship is condition dependent. Overall, these metabolite analyses provide critical insights into the activity-driven nature of the aging process.

Results {#s2}
=======

Age-related changes in metabolome diversity follow the lifespan curve {#s2-1}
---------------------------------------------------------------------

We maintained fruit flies (males) throughout their lifespan on two dietary regimens: standard sugar and yeast diet and fully defined diet ([@bib33]; [@bib31]). The defined diet, which was prepared from chemical components and mimicked dietary restriction conditions ([@bib4]), led to lifespan extension ([Figure 1A](#fig1){ref-type="fig"}), similar to the well-characterized effect of dietary restriction ([@bib33]). Our design and choice for sampling age groups were also similar to the previous studies, which analyzed gene expression during *Drosophila* aging ([@bib56]; [@bib45]), except that we increased the number of samples at the end of the lifespan curve, including very old flies, which allowed us to better examine changes associated with advanced age.10.7554/eLife.02077.003Figure 1.Dynamics of metabolite diversity throughout lifespan.(**A**) The number of detected nontargeted metabolites rises and then levels off as a function of cohort\'s age. Age-dependent changes in the number of detected metabolites (red curve) and intensity of total signal (blue curve) for nontargeted (two left panels) and targeted (two right panels) metabolites for standard (two upper panels) and defined (two lower panels) diets are shown. The lines were drawn using cubic polynomial fit function. Triangles mark data for the separately collected replicates for each age group. Significance for age-associated pattern in metabolite diversity was established using repeated measures ANOVA and was significant for nontargeted metabolites (p\<6 × 10^−6^) but not significant for targeted metabolites (p\>0.2). The corresponding lifespan curves are shown in black in each panel, and the curves in grey (for the other diet) are shown for convenient comparison of survivorship on the two diets. Mean lifespan of flies on standard and defined diets was 50.8 and 64.4 days, respectively (log-rank test \[p\<0.001\]). (**B**) Metabolites which registered at zero in at least one sample (21 total samples \[three associated replicates for each of the 7 age groups\]) were isolated from the dataset and, for visualization purposes, non-detected signals (ones registering at 0) were changed to 1 × 10^−5^ and Log~10~ transformed with the remaining signals. Accordingly, points of non-detection in black along with the color gradient of the mass-spectrometry peak intensities for detected signals are provided on two age-supervised hierarchically clustered heatmap images. For comparison purposes, only metabolites overlapping in both dietary regimens were used. Side bracket exemplifies rises in age-associated metabolites. Side bars highlight metabolites from the lipid fraction (yellow). Other metabolites are shown in black in this bar. (**C**) Histograms show overlaps in the distribution of signal intensities for all nontargeted metabolites vs targeted metabolites used to construct heat map images in **B**.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.003](10.7554/eLife.02077.003)10.7554/eLife.02077.004Figure 1---figure supplement 1.Correspondence in late life transition between metabolite diversity and mortality.For metabolite diversity, each triangle represents a sample at a given age, wherein a total of three replicates were used per age group. Circles correspond to the number of dead flies at each respective age. The lines were drawn using cubic polynomial fit function.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.004](10.7554/eLife.02077.004)

Our metabolite profiling platform detected \>15,000 unique analytes (nontargeted, non-redundant, de-isotoped LC-MS peaks), whose relative abundance was followed as a function of age. We found that the number of detected metabolites was lowest in the young flies in each dietary group and increased as a function of age (repeated measures ANOVA, p\<6 × 10^−6^ for each diet). On the other hand, the overall signal (the sum of signals for all molecular species detected) slightly decreased throughout lifespan ([Figure 1A](#fig1){ref-type="fig"}). As metabolites were extracted from the same number of flies at each time point, the decrease in total signal may represent lower biomass in older flies, whereas the number of detected metabolites indicated increased metabolite diversity during the aging process. This pattern was observed in each replicate sample and in each diet.

Interestingly, the rise in the number of detected metabolites was steady during adulthood, yet leveled off (and even slightly decreased) at the most advanced ages ([Figure 1A](#fig1){ref-type="fig"}). This transition in the metabolite diversity corresponded to the late-life transition in the lifespan curves and mortality ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), suggesting relationship between metabolite diversity and the aging process. In contrast, analysis of metabolite diversity using a panel of 205 known metabolites did not show significant age-associated trends ([Figure 1A](#fig1){ref-type="fig"}). Furthermore, the distribution of signal intensities between targeted metabolites and metabolites, which show diversity fluctuations throughout lifespan were different by few orders of magnitude ([Figure 1B,C](#fig1){ref-type="fig"}), suggesting that the latter generally corresponded to molecules of low abundance and were not due to errors of detection. Also, changes in metabolite diversity could not be attributable to the presence of yeast-derived metabolites in our diet, since the chemically defined diet contained no cellular products. Lastly, the observed changes in metabolite diversity could be explained by the presence of outliving cohorts in samples near the end of the lifespan curve, as previously proposed for mortality rates ([@bib11]). These data suggest a fair degree of synchronization between damage accumulation, expressed by the pattern of metabolite diversity, and the mortality pattern, including their changes in late life.

Metabolome remodeling defines progression of aging {#s2-2}
--------------------------------------------------

Among the signals consistently detected in all aging samples (those showing no difference in diversity), there may be metabolites that are passengers or drivers of the aging process, similar to the genes with age-associated differential expression ([@bib30]; [@bib13]; [@bib20]; [@bib44]; [@bib52]). Using repeated measures ANOVA and stringent statistical cut-off that estimated \<0.2% of false positives ('Materials and methods'), we identified 2234 and 2216 metabolites (∼14% of all detected metabolites) that qualified as age-associated in the standard and defined diets, respectively. This revealed widespread and dynamic metabolome reorganization throughout lifespan. Of the detected age-associated features, 1,066 were common to both dietary regimens ([Figure 2A](#fig2){ref-type="fig"}). These molecules exhibited very similar trajectories of change between the two diets (median Pearson correlation coefficient = 0.76), in contrast to the lack of such correlation when using all metabolite pairs between the diets (permutation test p\<0.001) ([Figure 2B](#fig2){ref-type="fig"}). To further characterize these age-related metabolites, we performed two types of scaling: between-group (a metabolite was scaled across both dietary conditions) and within-group (a metabolite was scaled within each dietary condition). Principal component analysis (PCA) of the between-group scaled values segregated samples first by diet and then by age ([Figure 2C](#fig2){ref-type="fig"}), suggesting that the magnitudes of these metabolites were affected by dietary conditions. On the other hand, PCA of the within-group scaled data revealed an age-dependent, but diet-independent segregation, with the replicate samples of both diets grouping closely together ([Figure 2D](#fig2){ref-type="fig"}). Thus, these metabolites indeed followed very similar trajectories with age, after normalization of differences in their intensity levels. Furthermore, most age-related changes in metabolite intensity (levels hereafter for simplicity) within individual diets did not exceed 4--8-fold across lifespan ([Figure 3A,B](#fig3){ref-type="fig"}), which was consistent with the differences in gene expression between *Drosophila* subjected to dietary restriction or stress ([@bib56]; [@bib45]; [@bib18]; [@bib27]). These data show that diet- and age-influenced changes in metabolome remodeling throughout lifespan closely recapitulated transcriptional changes and progression of aging.10.7554/eLife.02077.005Figure 2.Age- and diet-associated changes in metabolite levels accompany *Drosophila* aging.(**A**) Venn diagram of age-related features for two dietary regiments. The diagram shows that a large fraction of detected age-related features overlap between the two diets ('overlapping metabolites'). (**B**) Kernel Density Plot showing the distribution of Pearson correlation coefficients of the overlapping metabolites between the two diets (color). The coefficients for the total metabolites (gray) are shown for comparison. (**C** and **D**) Clustering of the overlapping metabolites by Principal Component Analysis. Squares and triangles denote standard and defined diets, respectively. Each plot includes three replicates per age. (**C**) Plot with scaling expression values across diets. In this plot, individuals are separated according to their ages and diets. (**D**) PCA plot with diet-specific scaling separates individuals according to their ages only.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.005](10.7554/eLife.02077.005)10.7554/eLife.02077.006Figure 3.Distribution of fold-changes for age-related metabolites.(**A** and **B**) Fold-change differences within standard (**A**) and defined (**B**) diets were calculated by comparing changes in intensity from the ratio of maximum to minimum lifespan-associated values. (**C**) Inter-dietary differences are shown in two heatmap panels after their separation into twofold thresholds, which also show metabolite remodeling during aging. Heatmaps were generated as follows. Replicate values were averaged and then scaled within individual and also across the diets. The resulting matrix was then subjected to age-guided complete hierarchical clustering using hclust algorithm in R where ages were assigned to columns and individual metabolites were assigned to rows. The resulting image allows convenient visualization of clusters containing metabolites with common trajectories (left side), which may also show inter-dietary differences in levels (right side). Side bars were added to highlight metabolites derived from the lipid fraction and also trajectories bearing strong correlation to lifespan curves (Pearson coefficient \|*r*\| \>0.75, color coded for each diet). Age-related trajectories were derived from trimming the distance matrix into 12 k-means clusters using rect.hclust function in R. Plots in each box represent averages of the scaled values of contributing metabolites whose number is listed in at the top of each graph.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.006](10.7554/eLife.02077.006)

Distinct and common age-related metabolite patterns characterize short- and long-lived flies {#s2-3}
--------------------------------------------------------------------------------------------

We explored the relationship between changes in age-related metabolites and longevity. We carried out k-mean clustering to group metabolites with similar trajectories, separately for those with below twofold and above twofold inter-dietary changes ([Figure 3C](#fig3){ref-type="fig"}), which showed that the diet-influenced changes were relatively underrepresented. Specifically, among the 1,542 age-related metabolites common to both diets, 76% showed less than twofold changes between the two diets ([Figure 4A](#fig4){ref-type="fig"}), indicating that the influence of diet was noticeable, but mostly small in magnitude. These age-related changes may be linked to longevity as there was high prevalence of strong correlations (both positive and negative) between individual metabolite levels across lifespan and lifespan curves ([Figure 4B](#fig4){ref-type="fig"}). While only a small fraction of metabolites showed more than twofold changes between the diets, they typically exhibited strong correlation with lifespan, suggesting they might represent mechanisms through which dietary modification (e.g., dietary restriction) affected longevity. Next, to visualize the changes in metabolite levels during aging, we performed hierarchical clustering on both within-group and between-group scaled data for all signals commonly changing with age in both diets ([Figure 4C](#fig4){ref-type="fig"}). Interestingly, a very large fraction of metabolites that decreased with age was derived from the lipid fraction, and this observation applied to both diets ([Figure 4C](#fig4){ref-type="fig"}). Lipid profiles also declined with age in other animals ([@bib20]; [@bib28]; [@bib49]), suggesting that our analysis captures a general scheme of age-related changes in lipid metabolism. Among decreases, metabolites in clusters 6 and 8 declined more rapidly beginning in early, very young samples, suggesting that these signals had an earlier role, for example, during development and morphogenesis. In fact, age-related transcripts with the roles in morphogenesis experienced similar trends (Clusters 6, 7, [Figure 5A,B](#fig5){ref-type="fig"}). Although most of the decreases in clusters 6 and 8 were significant, they were not strongly different between the diets. This may reinforce the idea of the developmental role for these lipid profiles as flies were reared on the standard medium until day 3 post eclosion, before the transfer to dietary restricted media. In contrast, most polar metabolites increased with age and their rates of change between the diets were more dynamic ([Figure 5C](#fig5){ref-type="fig"}). In summary, the majority of age-related trajectories were very similar in both diets: they showed strong correlations to lifespan curves and were largely continuous as they followed trajectories observed in younger samples, while very few showed mid-life reversals (clusters 10--12) ([Figure 4D](#fig4){ref-type="fig"}). Some of the variations in metabolite magnitude between the diets, on the other hand, may be responsible for the observed lifespan differences.10.7554/eLife.02077.007Figure 4.Common and distinct patterns of metabolite remodeling during the aging process.(**A**) Fold-change differences between common age-related metabolites from two dietary conditions (inter-dietary differences). Fold change was calculated using averages of individual metabolite levels across each lifespan. (**B**) Distribution of Pearson coefficients. The Kernel-Density function in R was used to plot the distribution of all Pearson coefficients representing correlations between each of the age-related metabolites and lifespan curves for standard (green) and defined (purple) diets. Signals were split into groups that showed inter-dietary differences of under (solid lines) or above (dashed lines) twofold-change. (**C**) Signals were clustered using methods described in [Figure 3C](#fig3){ref-type="fig"} legend. Side bars were added to highlight positions of the metabolites bearing statistically significant inter-dietary differences (Student *t* test, p\<0.05), metabolites meeting above twofold inter-dietary change, metabolites from the lipid fraction, and metabolites bearing strong correlation to lifespan (Pearson coefficient \|*r*\| \>0.75, color coded for each diet). (**D**) Age-related trajectories were derived from the hierarchical tree as described in [Figure 3C](#fig3){ref-type="fig"} legend.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.007](10.7554/eLife.02077.007)10.7554/eLife.02077.008Figure 5.Age-related transcripts and metabolites follow similar trajectories and show a delayed response under lifespan-extending dietary conditions.One way repeated measures ANOVA was used to identify transcripts with age-related changes at p\<0.0013. A total of 1171 features showed significance in both diets. (**A**) Normalization and clustering were performed according to the procedures described for [Figure 3C](#fig3){ref-type="fig"} legend. Each box represents individual clusters trimmed from hierarchically clustered tree using hclust algorithm in R. The number of genes contributing to each cluster is provided in the bottom left corner. (**B**) ClusterProfiler ([@bib55]) package in R ([@bib55]) was used to test for enrichment for Biological Process ontology in Clusters 1--12 in (**A**). Clusters 3, 10, and 12 did not enrich and therefore are not present. (**C**) Comparison of diet-dependent and diet-independent frequencies in gene and metabolite expression data. Frequencies of diet-dependent to diet-independent changes in gene expression and metabolites were obtained from signals provided by clusters 112 in panel **A** and [Figure 4D](#fig4){ref-type="fig"}, respectively. Differences that were continuous across lifespan were categorized as progressive, and those that were not as intermittent. (**D**) Average trajectories of upregulated (solid lines) and downregulated (dashed lines) signals in gene (top panel) and metabolite (bottom panel) expression datasets. For gene expression, the upregulated trajectories are averages of all signals from Clusters 1--5 shown in panel **A**, while all downregulated signals were derived from Clusters 6--8. Similarly, the global increases and decreases in metabolite levels were generated by averaging signals in Clusters 2--4 and Clusters 5--8, respectively, from [Figure 4D](#fig4){ref-type="fig"}. Plots show normalized trajectories\' values, which were obtained using quadratic polynomial fit through sample replicates. Points indicate sampled ages.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.008](10.7554/eLife.02077.008)

Similar changes in age-related metabolite and transcript profiles between short- and long-lived flies {#s2-4}
-----------------------------------------------------------------------------------------------------

If the observed global changes in metabolite levels are biologically relevant, we should expect to see similar patterns in gene expression across lifespan. For this, we analyzed a gene expression data set that sampled mated female flies raised similarly to our two dietary regimens ([@bib45]). By applying similar statistical methods as those used for identifying the age-associated metabolites, we identified 1172 age-associated genes (ca. 8% of total) common to both diets (repeated measures ANOVA, p\<0.0013). Clustering analysis revealed that about 70% of age-related genes also featured gradual transitions throughout lifespan, both increasing (clusters 2 through 5) and decreasing (clusters 6 through 8) with age ([Figure 5A](#fig5){ref-type="fig"}). We used Gene ontology (GO) ([@bib2]) to test for enrichment of biological processes within each cluster and found that longevity in dietary restricted (DR) flies was associated with reduced metabolism (cluster 2), increased transport (cluster 11) and altered response to pathogens, albeit early in life (cluster 4) ([Figure 5B](#fig5){ref-type="fig"}). Similarly to previous studies in mammals and other species, genes with increased levels in cluster 1 were enriched for stress response genes, whose expression rose at slower rate in DR flies, suggesting that improved homeostasis in these individuals may reduce the need for certain stress protection ([@bib30]; [@bib13]; [@bib44]). Another interesting observation was that all clusters, except for clusters 4 and 5, were enriched for non-overlapping GO terms, suggesting that the age-related changes in distinct biological processes proceeded synchronously. We suggest that this should also apply to nontargeted metabolites.

To compare metabolite and gene expression data further, we examined the frequency of diet-dependent vs diet-independent changes (e.g., trajectories that trended at different rates, levels and directions between the diets) ([Figure 5C](#fig5){ref-type="fig"}). First, for transcript changes, there were two types of diet-dependent effects: progressive, which differed at all age points (clusters 1--3, 8, 10 and 11) and intermittent which differed at some, but not all age points (clusters 6, 9 and 12). The diet-independent effects, however, predominated (68%) and fell into clusters 4, 5 and 7. Strikingly, we observed similar frequencies for age-related metabolites whereby clusters 2, 3, 6 and 10 can be categorized as diet-independent making up to 62% of total age-related signals common to both diets. The remaining fraction represented both progressive (clusters 4, 5, 7, 8, and 11) and intermittent (clusters 1, 9 and 12) effects. The diet-dependent differences in metabolite levels were more obvious after the clusters were separated into groups with below and above twofold inter-dietary difference ([Figure 3C](#fig3){ref-type="fig"}). The observed gradual, dynamic metabolome remodeling throughout lifespan, including both increases and decreases in metabolite signals, implied a role of predetermined, programmatic (but not necessarily programmed), genetically-defined aging ([@bib45]; [@bib50]; [@bib12]). Importantly, similarities between their trajectories indicate that age-related metabolites effectively recapitulate gradual and continuous aging transitions. We propose that the vast majority of age-related metabolite trajectories are directly related to aging and may contribute to its manifestation and/or delay.

Coordinated delays in transcriptome and metabolome remodeling in long-lived flies and in late life {#s2-5}
--------------------------------------------------------------------------------------------------

We further examined coordination in transcriptome and metabolome remodeling by examining transcript and metabolite signals that changed in both dietary groups. Interestingly, these age-related changes (both increases and decreases common to both diets) in either gene expression or metabolite levels were delayed in long-living flies ([Figure 5D](#fig5){ref-type="fig"}). Moreover, metabolome remodeling represented by these signals was decelerated with age within each dietary group (i.e., the signals initially showed robust changes, but then almost leveled off). Together with the analyses that revealed the diet-associated changes in the metabolome composition, these findings suggested that a change in lifespan involves both a delay in age-related metabolome and gene expression remodeling and a change in the set of expressed metabolites and genes at any point throughout lifespan. These data also resemble the metabolite diversity pattern ([Figure 1A](#fig1){ref-type="fig"}) and suggest a close relationship between activity-dependent damage accumulation and aging.

Lifespan extension is associated with decreased metabolism and tolerance to damage {#s2-6}
----------------------------------------------------------------------------------

Behavioral or genetic alterations of nutrient sensing pathways and metabolism lead to lifespan extension in diverse phyla ([@bib32]; [@bib45]; [@bib36]; [@bib41]), suggesting that metabolite profiling could capture metabolic alterations between aging control and long-lived flies. We addressed this by examining several metabolic pathways by screening for age-associated profiles among 205 annotated metabolites, which we recalled from nontargeted spectral features and confirmed using authentic in-house standards. Among these, 81 metabolites displayed age-associated trends under both dietary regimens (repeated one-way ANOVA, p\<0.05) and were associated with biosynthesis of amino acids, lipids, energy homeostasis, and damage production ([Figure 6](#fig6){ref-type="fig"}). As a whole, the clustering analysis by means of inter-dietary comparison of these age-associated molecules showed no prevalence for metabolite downregulation in flies from the dietary restricted regimen: there was nearly an equal frequency of diet-dependent to diet-independent effects ([Figure 7A,B](#fig7){ref-type="fig"}). Examination of the molecules within individual clusters (as they share similar age-related trajectories) led to several important observations. First, we find that, as in the case of nontargeted metabolite profiles, decreases of targeted signals were predominantly associated with lipids (cluster 1, [Figure 7A,B](#fig7){ref-type="fig"}). Eighty percent of metabolites in this cluster were triglycerides (TAGs) and diacylglycerols (DAGs), all of which normally rise highly during larval growth but decline thereafter ([@bib10]). The high developmental expression of these lipid species may explain their rapid drop during adulthood in our data, well before the first major change in survivorship curves. Such patterns are also present within decreasing clusters of nontargeted metabolites that contain a large number of metabolites from the lipid fraction (clusters 6, 8, [Figure 4D](#fig4){ref-type="fig"}). Also, the age-associated tendencies between our standard and DR-like regimens suggest increased synthesis (or reduced utilization) of lipids in long-living flies and agree with higher lipid stores and starvation resistance of DR flies in previous studies ([@bib8]; [@bib22]). In contrast, we observed a progressive age-associated increase in the cholesteryl esters in our long-living flies compared to controls (cluster 11). While accumulation of this lipid class has been inferred to negatively affect mammalian fitness ([@bib29]), it may extend *Drosophila* lifespan via increased pathogen protection ([@bib9]). Second, consistent with the effects of dietary restriction, we find that downregulated metabolites in long-lived flies (clusters 5--8, n = 39) were associated with insulin signaling, energy homeostasis, and amino acid metabolism ([Figure 7C](#fig7){ref-type="fig"}). Third, a striking observation was the elevation of methionine sulfoxide, which represents damage ([@bib38]; [@bib48]; [@bib24]), and taurine, a product of cysteine degradation and a component of bile acids ([@bib34]; [@bib7]), in long-lived but not in control flies (cluster 9, [Figure 7D](#fig7){ref-type="fig"}). The levels of these molecules started to decline at the point corresponding to high mortality in both groups (at 40 and 50 days, respectively), which may be due to the low levels of these metabolites in cohorts surviving to old age ([@bib11]). Tryptophan is also a lifespan limiting amino acid ([@bib14]) and a member of that cluster showing a similar pattern. Such bell-shaped lifespan-associated curves are not surprising as degradation of tryptophan and rise of the downstream metabolite kynurenine (also lifespan limiting metabolite \[[@bib40]\] expressed higher on the defined diet) were reported in older individuals ([@bib37]; [@bib17]). In sum, the higher levels of methionine sulfoxide, tryptophan, and kynurenine in our long-living flies are consistent with the notion that lifespan extension by dietary restricted regimen may increase damage tolerance. We suggest that long-living species may also feature higher levels of lifespan-limiting molecules and that metabolome remodeling upon dietary interventions activates compensatory mechanisms. Whether this is broadly applicable to a variety of lifespan-extending conditions and to long-lived species is a possibility worth exploring.10.7554/eLife.02077.009Figure 6.Identification and metabolic pathway representation of significant age-related targeted metabolites.(**A**) Overview of molecules significantly associated with aging according to biological processes in both diets (repeated measures ANOVA, p\<0.05). (**B**) Venn diagram showing the number of significantly changing metabolites with relation to the number of metabolites uniquely significant to standard (solid) or defined (dashed) diets.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.009](10.7554/eLife.02077.009)10.7554/eLife.02077.010Figure 7.Metabolic signatures of aging in control and dietary restricted flies.Annotated (targeted) metabolites were derived from raw nontargeted data and represent only signals of established chemical identities. (**A** and **B**) Patterns of targeted metabolites. Clustering and graphing were done identically to the procedures described for [Figure 3C](#fig3){ref-type="fig"} legends. Side bars highlight lipid species and cluster boundaries that correspond to consequently arranged plots in (**B**). (**C**) Metabolite set enrichment analysis was performed by MetaboAnalyst 2.0 ([@bib54]). The panel overviews low expressing signals in long-living flies (Clusters 5--8). (**D**) Metabolites representing known damage and lifespan limiting factors overlayed with lifespan curves for standard (solid) and defined (dotted) diets. Taurine and kynurenine showed statistically significant inter-dietary changes across lifespan. Methionine sulfoxide differed significantly between 10 and 25 day groups (Student *t* test p\<0.50). Tryptophan showed no significant inter-dietary differences at 60--63 days. Circles correspond to sampled age groups, whereby z-scored expression values are generated from averages of randomly measured replicates representing separately sampled cohorts in standard (green) or defined (purple) diets.**DOI:** [http://dx.doi.org/10.7554/eLife.02077.010](10.7554/eLife.02077.010)

Discussion {#s3}
==========

Aging was suggested to result from accumulation of molecular damage that leads to age-associated decrease in organism\'s fitness ([@bib39]; [@bib23]). Yet, individual damage forms, for example, damage caused by reactive oxygen species, proved to be both condition- and species-specific, challenging the relevance of damage accumulation to aging ([@bib6]). However, aging may be associated with cumulative damage, whereby mild effects of the myriad damage forms may exhibit additive effects on organism\'s fitness. In this case, increased mortality may be associated with inevitable accumulation of heterogeneous damage forms, which are also condition dependent. For example, in interventions that extend lifespan (e.g., dietary restriction) reduction of some damage forms may be compensated by accumulation of other forms of damage. In addition to the role of damage, the contribution of changes in the levels of purposely used metabolites remains unclear. An age-related remodeling has been described for transcriptome, epigenome, and proteome, but how these changes relate to each other and what the role of metabolome remodeling is in the progression of aging is not well understood.

Our report offers insights into the nature of aging through a comprehensive assessment of changes in a large number of endogenous small molecules throughout *Drosophila* lifespan. Our initial observations showed that global metabolite profiling effectively recapitulated distinct stages of the aging process and revealed metabolites that strongly correlate with organismal survivorship. Specifically, analysis of nontargeted features showed a robust increase in the number of detected molecules as a function of age, followed by cessation of the increase in late life. This pattern corresponded to the transitions in the lifespan curves and was also in concert with the observed decelerated metabolome remodeling in late life, altogether supporting the idea that aging subsides at advanced ages. On the other hand, the increase in the number of detected metabolites clearly differed from general age-associated changes, and its commonalities in the two dietary conditions exclude the role of exogenous compounds. The extended metabolome composition may include by-products that affect viability and damage forms that reach and pass the detection thresholds during organism\'s aging ([@bib43]), but they likely represent only the tip of the iceberg of cumulative damage. Further advances in instrumentation and sensitivity of metabolite profiling should expose additional metabolites that characterize cumulative damage.

We further followed age-related trajectories of 1066 individual metabolites common to short- and long-living flies and found that the trajectories of most metabolites correlated between the two dietary groups, yet varied in magnitude from initial to final concentration changes, suggesting that differences in accumulation of individual metabolites, in addition to the overall pattern, were responsible for lifespan differences. A substantial fraction of these signals showed biologically-relevant differences during aging and correlated with survivorship of flies. Metabolite trajectories were gradual and continuous starting from early adulthood, with very few signals showing mid-life reversals. These results are generally consistent with the observations from the studies on transcript and protein profiles across diverse aging populations ([@bib56]; [@bib45]; [@bib50]). Indeed, our analysis of age-associated gene expression involving both control and dietary restricted long-lived individuals indicates that metabolites and transcripts exhibit nearly identical frequencies of diet-dependent to diet-independent effects. Thus, metabolites, similarly to genes, may exhibit diverse lifespan-regulatory roles. Similarly to targeted metabolite profiling in mammals ([@bib52]), the gradual transitions in thousands of nontargeted metabolites may be used to derive a signature that predicts survivorship across variable lifespans. Consistent with this idea, we observed a delay in the age-associated changes in transcripts and metabolites in the case of longer-lived flies. Thus, a change in lifespan (here, in response to a dietary regimen, but this should also apply to longevity-related genetic manipulations and evolutionary processes that affect species lifespan) involves both a change in the expressed transcripts and metabolites at any time throughout lifespan and a delay in age-related changes for those transcripts and metabolites that commonly change with age in both conditions (or genotypes).

A significant overlap between metabolites that show age-associated changes between the diets can also identify the biological, rather than the chronological, aging component. Together with the component that reflects diet-specific patterns of metabolite change, it should help define the aging process in model systems and beyond. For instance, comparison of inter-dietary age-associated trajectories using known metabolites reveals that a fraction of downregulated signals were associated with slower metabolism in long-living flies. However, we also found that the molecular species with higher levels in long-living flies represented damage forms. While the inter-dietary differences for such increases were below twofold and varied in significance across age, the data nonetheless implies that lifespan extension may be associated with damage tolerance via compensatory mechanisms. In fact, long-living flies, when compared to control, featured a large set of nontargeted metabolites that increase at higher levels. How many of these metabolites represent damage will need to be determined through structural elucidation of nontargeted signals.

Overall, from the current study the aging process emerges as a gradual, dynamic metabolome remodeling that involves changes in the levels (both increases and decreases) in numerous cellular metabolites, delays in these changes in late life and under conditions that lead to longer lifespan, and accumulation of damage, whose condition-dependent cumulative effects may impact survivorship.

Materials and methods {#s4}
=====================

*Drosophila* lifespan extension and sampling {#s4-1}
--------------------------------------------

Progenies used in aging assays and metabolite profiling experiments were prepared by mating wild-type animals of Canton-S background, which were backcrossed for seven generations. Aging progeny was grown on rich media ([flystocks.bio.indiana.edu](http://flystocks.bio.indiana.edu)) at regular density. Newly eclosing F1 adult males were collected for 3 days, mixed and distributed within vials containing respective food for sampling at predetermined ages. The recipes for preparation of the defined diet have been described ([@bib53]). Between 30 and 50 flies were sampled at each age, rapidly frozen in liquid nitrogen and stored at −80°C. Once all samples were collected they were immediately processed for LC-MS profiling.

Metabolite profiling {#s4-2}
--------------------

Three LC-MS methods were used to measure polar metabolites and lipids in whole fly homogenates. Conditions for the analysis were set using a panel of routinely analyzed 293 standards. Polar and lipid-associated species were extracted from 7 and 2 flies, respectively, in three separate replicates which were ran in randomized order. All data were acquired using an LC-MS system comprised of a Nexera X2 U-HPLC (Shimadzu, Marlborough, MA) and a Q Exactive hybrid quadrupole orbitrap mass spectrometer (Thermo Fisher Scientific; Waltham, MA). Hydrophilic interaction liquid chromatography (HILIC) analyses of water soluble metabolites in the positive ionization mode were carried out by extracting 10 µl homogenate using 90 µl of 74.9:24.9:0.2 vol/vol/vol acetonitrile/methanol/formic acid containing stable isotope-labeled internal standards (valine-d8, Isotec; and phenylalanine-d8, Cambridge Isotope Laboratories; Andover, MA). The samples were centrifuged (10 min, 9000×*g*, 4°C) and the supernatants were injected directly onto a 150 × 2 mm Atlantis HILIC column (Waters; Milford, MA). The column was eluted isocratically at a flow rate of 250 µl/min with 5% mobile phase A (10 mM ammonium formate and 0.1% formic acid in water) for 1 min followed by a linear gradient to 40% mobile phase B (acetonitrile with 0.1% formic acid) over 10 min. The electrospray ionization voltage was 3.5 kV and data were acquired using full scan analysis over m/z 70--800 at 70,000 resolution and a 3 Hz data acquisition rate. Negative ion mode analyses of polar metabolites were achieved using a HILIC method under basic conditions. Briefly, 30 µl homogenate was extracted using 120 µl of 80% methanol containing inosine-^15^N4, thymine-d4, and glycocholate-d4 internal standards (Cambridge Isotope Laboratories; Andover, MA). The samples were centrifuged (10 min, 9000×*g*, 4°C) and the supernatants were injected directly onto a 150 × 2.0 mm Luna NH2 column (Phenomenex; Torrance, CA) that was eluted at a flow rate of 400 µl/min with initial conditions of 10% mobile phase A (20 mM ammonium acetate and 20 mM ammonium hydroxide in water) and 90% mobile phase B (10 mM ammonium hydroxide in 75:25 vol/vol acetonitrile/methanol) followed by a 10 min linear gradient to 100% mobile phase A. MS full scan data were acquired over m/z 70--800. The ionization source voltage is −3.0 kV and the source temperature is 325°C. Lipids were extracted from 10 µl of homogenate using 190 µl of isopropanol containing 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids; Alabaster, AL). After centrifugation, supernatants were injected directly onto a 150 × 3.0 mm Prosphere HP C4 column (Grace, Columbia, MD). The column was eluted isocratically with 80% mobile phase A (95:5:0.1 vol/vol/vol 10 mM ammonium acetate/methanol/acetic acid) for 2 min followed by a linear gradient to 80% mobile-phase B (99.9:0.1 vol/vol methanol/acetic acid) over 1 min, a linear gradient to 100% mobile phase B over 12 min, then 10 min at 100% mobile-phase B. Full scan MS analyses (m/z 400--1000) were carried out in the positive ion mode using full scan analysis at 70,000 resolution and 3 Hz data acquisition rate. All raw data were processed using Progenesis CoMet software (version 2.0, NonLinear Dynamics) for feature alignment, signal detection, and signal integration. Signal peak areas were converted into numerical intensity values and normalized to internal standards added to each sample and to total signal at each time point. The raw peak intensity values are provided as Supplementary dataset ([@bib3]).

Statistical analysis {#s4-3}
--------------------

Age-associated signals were identified using repeated measures ANOVA, and significance was established at p\<0.0014 (\<0.2% of false positives) and False discovery rate (FDR) of 0.029. To calculate FDR, we first established relationships between error rate and its corresponding p value ([@bib51]) and used an adjusted p value at the interface that marked transition between linear and exponential rise in error rate. Then, FDR was calculated using compute.FDR function in R brainwaver package with the significance thresholds established above. Data analysis was also carried on in the R environment; information on packages used in this study can be found within respective figure legends. Metabolite enrichment analysis was performed in MetaboAnalyst 2.0 ([@bib54]). For gene expression analysis, we used a dataset that was normalized using RMA package of Bioconductor in R and kindly provided by Dr Scott Pletcher ([@bib45]). Age-associated gene expression signatures were identified identically to the metabolites above and corrected for multiple testing (p\<0.0013, FDR = 0.025) using aforementioned computations and significance threshold selections.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Age- and diet-associated metabolome remodeling characterizes the aging process driven by damage accumulation" for consideration at *eLife*. Your article has been evaluated by a Senior editor, a Reviewing editor, and 2 reviewers.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

One of the major concerns voiced by both reviewers and shared by the editor is that this work is strongly interpreted by the authors to support the aging hypothesis recently formulated by the senior author of the manuscript. While such a trend is understandable, it is not obvious that the presented data cannot be explained by other aging hypotheses. Furthermore, authors would be advised to try to provide more evidence that metabolome changes and survival changes are really as well correlated as claimed. For instance, to provide additional support for the aging hypothesis promoted by the authors, one may need to show that differences in survival curves between dietary controlled animals and common animals can be linked with differences in the shapes of metabolite repertoire curves. It is not clear however, whether data provided by the authors could unambiguously support such a claim. Thus, in the absence of additional evidence, a much more balanced data interpretation considering other aging hypotheses would be advised.

Other issues to address:

*Reviewer 1*:

In this work, the authors performed metabolic profiling in aging flies and also in context of caloric restriction. To my knowledge, this is the first metabolic profiling of aging in flies, and one of the first in context of aging, and therefore will be of interest to researchers in the field. The work is largely sound, though some aspects, including the methodology, require further clarification, and at times the authors\' interpretations of the results and how it fits our current knowledge of aging were unclear to me, as detailed below.

One concern I have is that there are aspects of the methods that I think require further clarification. One aspect that wasn\'t clear to me is whether the authors used females and males? [Figure 1](#fig1){ref-type="fig"} only refers to males but if the authors only used males then they should explicitly mention this in the manuscript. Also, the authors write that: "As metabolites were extracted from the same number of flies at each time point, the decreased total signal may represent lower biomass in older flies"; but then shouldn\'t the results be normalized by biomass or by the total signal? I\'m not an expert in metabolic profiling, and thus could be mistaken, but this seems reasonable to me. Also, the authors write: "Using repeated measures ANOVA and stringent statistical cut-off that estimated \<0.2% of false positives (Materials and Methods)"; but I couldn\'t find where this is described in the Methods. A reference is made to an FDR of 0.029 which ∼3%. It also wasn\'t clear to me how FDR was estimated and significance established.

I think the authors can do a better job of placing their findings in context of current knowledge. There are several statements, in particular in the Introduction, that are not supported by a suitable reference. For example, the authors mention how "it is also known that lifespan can actually be increased under mild stress", which is called hormesis by various authors with important contributions in this context (e.g., Rattan). Also: "it is not known whether cumulative damage increases linearly or exponentially throughout lifespan"; yet various authors have quantified different types of damage (DNA mutations in aging tissues in mice by Vijg and co-workers, more recent quantifications of DNA mutations in human samples with NGS, etc).

I thought some statements and conclusions by the authors were unclear and/or not entirely supported by the data. For example: "This finding suggested that the observed metabolite pattern characterized cumulative damage." But have the authors considered that many changes with age are adaptive responses trying to fend off aging, as suggested by gene expression studies (e.g., see de Magalhaes et al. Bioinformatics 25:875-881)? I may be missing something but the interpretation of the results in context of cumulative damage wasn\'t clear to me. In the Discussion the authors write: "Aging was suggested to result from accumulation of molecular damage\..." and a few sentences later: "Alternatively, aging may be due to cumulative damage"; why should this be an alternative? "Accumulation of molecular damage" and "cumulative damage" mean the same to me.

Also: "Thus, the observed gradual, dynamic metabolome remodeling throughout lifespan, including both increases and decreases in metabolite signals, implied a role of predetermined, genetically-defined aging." It wasn\'t clear to me why this should be the case. Besides, even assuming this is the case, such genetic regulatory basis in aging has been shown by other studies, which should be mentioned (for a recent review see de Magalhaes, FASEB Journal 26:4821-4826; also Somel 2010 which is cited later in the manuscript but should also be mentioned in this context).

"These metabolite analyses provide critical insights into the nature of the aging process." While this type of work is novel, I think this is an overstatement. Many of the results obtained by the authors are in line with overall patterns and signatures of aging and CR, for example at the level of lipid metabolism and stress response genes (e.g., Plank et al. Molecular BioSystems 8:1339-1349). The authors should either be more clear about the insights from by their results or tone down their interpretation.

I would also suggest that the authors check the overlap between their gene expression results and the GenDR database of CR-related genes since these are genes demonstrated directly to affect CR-mediated longevity and may allow the authors to identify candidate regulators of CR longevity effects: <http://genomics.senescence.info/diet/>

Lastly, the authors write: "only a small fraction of metabolites showed more than 2-fold changes between the two diets"; are these given in the supplementary material? In fact, is the full data available as supplementary material or in a suitable repository?

Overall, this is an original and interesting work, though some aspects of the manuscript may be improved and clarified. It is possible that some of my comments reflect misunderstandings of mine. If so then I would suggest that the author uses my misunderstandings as an indication that such points might be made clearer in the manuscript.

It my usual policy to reveal my identity to the authors: Joao Pedro de Magalhaes.

*Reviewer 2*:

Avanesov et al describe a metabolome analysis of fruit fly aging, using both a standard and lifespan extending restricted diet. They find that 15% of metabolites levels change during aging; that the timing and speed of metabolite level changes during aging largely parallels those of mRNA, and is slower under lifespan extending dietary conditions; that the number of detected metabolites increases with age; that metabolites in the lipid fraction decrease with age and that this decrease is unrelated to diet effect/longevity. Also, interestingly, the rate of metabolome changes is decelerated during aging, though such deceleration is not observed in gene expression (although the latter data is from another experiment). The authors further find higher levels of potentially damage-representing metabolites in long-lived DR flies, than standard diet fed flies, which they suggest could be explained by extra stress resistance of DR flies.

Major points:

The data and the methods appear sound. My main objection is regarding how some results were interpreted. For me, the claims that metabolome changes are directly linked to mortality, and that metabolome changes reflect cumulative damage, are both overinterpretations. Specifically:

1\) "This transition in the metabolome diversity corresponded to the late-life transition in the survival curves, linking metabolome diversity with the aging process. Thus, while damage accumulation is continuous throughout adulthood, it decelerates at advanced stages of life."

For me, this does not link "metabolome diversity with the aging process", but only suggests a link. Second, how is it concluded that metabolome diversity reflects damage accumulation? This should be better explained, or the claim softened.

2\) "The observed changes in the metabolome uncovered a link between the aging process and metabolite diversity. They also suggested that many metabolites reaching detection in the course of aging may represent low levels of by-products or other damage forms."

Again, based on what?

3\) "The observed pattern provided additional insights into damage accumulation. For example, the number of newly detected species did not rise exponentially or linearly during aging, instead reflecting deceleration of aging in late life."

Again, this only assuming that the change in metabolite number reflects damage accumulation.

4\) "This data is also congruent with the damage pattern ([Figure 1B,C](#fig1){ref-type="fig"}) and confirms the links between activity-dependent damage accumulation and aging."

5\) "This pattern matched transitions in the mortality curves (\...)".

In order to claim this, the authors should first clearly define "transitions in the mortality curves"; i.e., the ages when transitions happen. They could then show that points when metabolite number changes or metabolite intensity level changes decelerate or accelerated correspond to these mortality transitions.

In summary, the general claim here is that because the change in metabolite number is correlated with mortality, the former should reflect molecular damage. This involves a lot of assumptions (which are not openly stated) and can only be a suggestion, not an observation.

Second, I am not sure if the mortality curves indeed are correlated with the change in detected metabolite number. In [Figure 1B-C](#fig1){ref-type="fig"}, the increase in metabolite diversity appears before mortality increases, it slows down when mortality increases. So I am not sure whether it could be concluded that deceleration in metabolite diversity refletcs "deceleration of aging in late life".

Perhaps the authors have data to support these claims, but then these should be more clearly explained.

10.7554/eLife.02077.012

Author response

*One of the major concerns voiced by both reviewers and shared by the editor is that this work is strongly interpreted by the authors to support the aging hypothesis recently formulated by the senior author of the manuscript. While such a trend is understandable, it is not obvious that the presented data cannot be explained by other aging hypotheses. Furthermore, authors would be advised to try to provide more evidence that metabolome changes and survival changes are really as well correlated as claimed. For instance, to provide additional support for the aging hypothesis promoted by the authors, one may need to show that differences in survival curves between dietary controlled animals and common animals can be linked with differences in the shapes of metabolite repertoire curves. It is not clear however, whether data provided by the authors could unambiguously support such a claim. Thus, in the absence of additional evidence, a much more balanced data interpretation considering other aging hypotheses would be advised*.

We revised the manuscript to provide a more balanced interpretation of the data and distance the manuscript from the recently formulated aging hypothesis. Instead, we elaborate on the widely accepted ideas of damage accumulation. The Introduction was also modified to reflect additional studies. We toned down conclusions based on the reviewers' comments. We have carried out additional analyses and provide new figures and panels in support of the changes in metabolite diversity and low-abundance metabolites. We hope that the responses to specific comments below and changes in the text fully address the issues identified during the review process.

*Other issues to address*:

Reviewer 1:

*In this work, the authors performed metabolic profiling in aging flies and also in context of caloric restriction. To my knowledge, this is the first metabolic profiling of aging in flies, and one of the first in context of aging, and therefore will be of interest to researchers in the field. The work is largely sound, though some aspects, including the methodology, require further clarification, and at times the authors\' interpretations of the results and how it fits our current knowledge of aging were unclear to me, as detailed below*.

*One concern I have is that there are aspects of the methods that I think require further clarification. One aspect that wasn\'t clear to me is whether the authors used females and males?* [*Figure 1*](#fig1){ref-type="fig"} *only refers to males but if the authors only used males then they should explicitly mention this in the manuscript*.

We used males. We now indicate this in three additional places (end of Introduction, beginning of Results and Methods).

*Also, the authors write that: "As metabolites were extracted from the same number of flies at each time point, the decreased total signal may represent lower biomass in older flies"; but then shouldn\'t the results be normalized by biomass or by the total signal? I\'m not an expert in metabolic profiling, and thus could be mistaken, but this seems reasonable to me*.

In the Methods section, we added information on normalization: "Signal peak areas were converted into numerical intensity values and normalized to internal standards added to each sample and to total signal at each time point." All of our analyses besides [Figure 1](#fig1){ref-type="fig"} used such normalized data. Our intention for presenting the original data in [Figure 1](#fig1){ref-type="fig"} was to point out any obvious trends in total signal as well as its relation to the increase in metabolite diversity. We believe this information is most useful to the readers. The main point is that the increased metabolite diversity is not due to increased signal.

*Also, the authors write: "Using repeated measures ANOVA and stringent statistical cut-off that estimated \< 0.2% of false positives (Materials and Methods)"; but I couldn\'t find where this is described in the Methods. A reference is made to an FDR of 0.029 which ∼3%. It also wasn\'t clear to me how FDR was estimated and significance established*.

We added the description of tools used in calculating FDR in Methods: "To calculate FDR, we first established relationships between error rate and its corresponding p value ([@bib51]) and used an adjusted p value at the interface that marked transition between linear and exponential rise in error rate. Then, FDR was calculated using compute.FDR function in the R brainwaver package with the significance thresholds established above."

*I think the authors can do a better job of placing their findings in context of current knowledge. There are several statements, in particular in the Introduction, that are not supported by a suitable reference. For example, the authors mention how "it is also known that lifespan can actually be increased under mild stress", which is called hormesis by various authors with important contributions in this context (e.g., Rattan)*.

This section was significantly revised. We added references to Rattan ([@bib46]; [@bib47]) and others ([@bib1]; [@bib15]) on damage conditioning and also on the limited number of damage markers used to assess the damage pattern as function of age. We also emphasized that earlier studies mostly left out late-life time points and were unable to address the remodeling pattern thoroughly.

*Also: "it is not known whether cumulative damage increases linearly or exponentially throughout lifespan"; yet various authors have quantified different types of damage (DNA mutations in aging tissues in mice by Vijg and co-workers, more recent quantifications of DNA mutations in human samples with NGS, etc)*.

The reviewer is correct about a large body of existing data characterizing damage and damage response during aging. We mentioned these studies in the Introduction in our revision. However, to our knowledge these studies never analyzed late life changes and this can lead to elusive assumptions about life-long changes in damage rates and responses. In addition, selected damage markers (e.g. DNA mutation rate, lipofuscin accumulation, ROS levels, etc.) are insufficient for assessing cumulative damage and their resolution is too low at the moment to conclude on the pattern of changes (beyond the fact that damage increases with age). In our study, we attempt to address these deficiencies by using non-targeted metabolite profiling and including multiple late time points to decipher the patterns of metabolite damage and their relationship to metabolism. We revised the text to better explain this point.

*I thought some statements and conclusions by the authors were unclear and/or not entirely supported by the data. For example: "This finding suggested that the observed metabolite pattern characterized cumulative damage." But have the authors considered that many changes with age are adaptive responses trying to fend off aging, as suggested by gene expression studies (e.g., see de Magalhaes et al. Bioinformatics 25:875-881)*?

This is an important point as we may be the first to employ metabolite diversity in making inferences about damage patterns. We are familiar with the nice meta-analysis study mentioned by the reviewer as well as with another one by Plank et al. and also with the datasets from Pletcher, Tower and Khaitovich groups and many others. Similarly, studies on aging DNA methylomes (e.g., Hannum et al. Mol Cell 2013) show bi-directional changes, for which additional evidence implicates some of them as adaptive. However, unlike bi-directional changes in the regulatory and/or responsive pathways the damage pattern is largely unidirectional and is always rising (e.g., oxidative damage, somatic DNA mutations, protein aggregates, etc. all rise with age). In our study, we show that metabolite diversity rises with age and the rises are largely represented by low abundance molecules. These considerations argue that the observed changes in metabolite diversity expose cumulative damage. In contrast, an analysis of non-targeted metabolites with steady diversity (ones detected in all ages) and known metabolites shows that they have bi-directional changes. We can only argue that this second type of change in metabolomes reflects biological activity (possibly adaptive responses too) and they should not be fully regarded as damage. We have made a distinction between the two by adding the following statement (Results): "Among signals consistently detected in all aging samples (those showing no difference in diversity) there may be metabolites that are passengers or drivers of the aging process which would be similar to the genes with age-associated differential expression ([@bib30]; [@bib13]; [@bib44])" We also commented on a possibility of adaptive changes contributing to the observed changes in metabolites.

*I may be missing something but the interpretation of the results in context of cumulative damage wasn\'t clear to me. In the Discussion the authors write: "Aging was suggested to result from accumulation of molecular damage\..." and a few sentences later: "Alternatively, aging may be due to cumulative damage"; why should this be an alternative? "Accumulation of molecular damage" and "cumulative damage" mean the same to me*.

To clarify, we replaced "alternatively" with "however". "Alternatively" referred to the original sentence which discussed individual damage forms, contrasting them with cumulative damage. Cumulative damage combines individual damage forms that accumulate, but often cannot be defined as causal factors. Many components of cumulative damage would have a very minor role when taken in isolation. For example, five molecules of a by-product produced by an enzyme during lifetime of a cell would not be "seen" by evolution, would not be detected by analytical methods, and would not show measurable role in aging when taken in isolation, but they would contribute, with the millions of other five-molecule by-product forms, to cumulative damage. Of course, this is how we think about the aging process, but we made sure the data interpretation in the manuscript is not biased by these ideas, which have been removed during revision.

*Also: "Thus, the observed gradual, dynamic metabolome remodeling throughout lifespan, including both increases and decreases in metabolite signals, implied a role of predetermined, genetically-defined aging." It wasn\'t clear to me why this should be the case. Besides, even assuming this is the case, such genetic regulatory basis in aging has been shown by other studies, which should be mentioned (for a recent review see de Magalhaes, FASEB Journal 26:4821-4826; also Somel 2010 which is cited later in the manuscript but should also be mentioned in this context)*.

In addition to Somel et al. ([@bib50]) on continuous transcript changes in aging primate brains, the revised manuscript also has additional citations (including the review mentioned by the reviewer). We also slightly modified the text to better explain this point.

*"These metabolite analyses provide critical insights into the nature of the aging process." While this type of work is novel, I think this is an overstatement. Many of the results obtained by the authors are in line with overall patterns and signatures of aging and CR, for example at the level of lipid metabolism and stress response genes (e.g., Plank et al. Molecular BioSystems 8:1339-1349). The authors should either be more clear about the insights from by their results or tone down their interpretation*.

We modified that last sentence of the Introduction and made changes throughout the text to limit the use of critical to more specific context such as in the "\...activity-driven nature of the aging process". By measuring metabolites as function of age between distinct dietary conditions and by analyzing late life points we provide support for the patterns of metabolite change and damage and show that the changes slow down and then stop at the very advanced time points. Our studies also open the door to using changes in metabolite diversity as readout for cumulative damage in age-related studies, and further improvement in sensitivity of this technology should increase the fraction of damage over functional metabolites. In our opinion, such global approach allows for a more comprehensive detection of damage compared to the analysis of selected damage types or selected makers. Lastly, by analyzing the effects of dietary restriction we show that lifespan increase may be associated with an increase in specific damage types.

*I would also suggest that the authors check the overlap between their gene expression results and the GenDR database of CR-related genes since these are genes demonstrated directly to affect CR-mediated longevity and may allow the authors to identify candidate regulators of CR longevity effects*: [*http://genomics.senescence.info/diet/*](http://genomics.senescence.info/diet/)

Thank you. We examined the overlap between significant age-associated gene expression in our analysis ([Figure 5A,B](#fig5){ref-type="fig"}) and the twenty Drosophila lifespan regulatory genes available at DenDR. llp5 was not represented in the gene expression dataset we used. As highlighted below, there is a good agreement between the genes that change expression with age and the genes required for the effect of DR. This encourages identification of lifespan regulating genes based on changes in their age-associated expression. We have also extended this comparison to Drosophila genes whose homologs affect lifespan in other species. As tabulated below, there is a greater overlap with such dataset in our manuscript (in [Author response tables 1 and 2](#tbl1 tbl2){ref-type="table"} below, we removed 16 genes whose expression was not mapped on our arrays).Author response table 1.The table was downloaded from the GenAge database and shows genes known to affect *D. melanogaster* lifespan. We asked if gene expression differences as function of age were significant for these *D. melanogaster* genes. We find that there is a good correlation as indicated by significant age-associated p values (highlighted cells).gene_symbolgene_idage-assoc p val. (Control diet)age-assoc p val. (DR diet)entrez_idgene_nameRpd3FBgn00158050.4818105470.21601182638565Histone deacetylase Rpd3Or83bFBgn00373240.285181195**0.046763434**40650Odorant receptor 83bchicoFBgn0024248**0.003887938**0.20551386864880Insulin receptor substrate-1gigFBgn00051980.4747975710.18066355140201gigasSir2FBgn00242910.321025147**0.003652163**34708Protein Sir2IndyFBgn00368160.113197528**0.006970164**40049I\'m not dead yetfoxoFBgn00381970.281422096**0.046040677**41709Forkhead box, sub-group OThorFBgn0261560**9.13398E-093.2467E-07**33569p53FBgn00390440.2020609440.2776168462768677CG33336 gene product from transcript CG33336-RBl(3)neo18FBgn0011455**0.0284312670.006074331**46260lethal (3) neo18CG11015FBgn00390440.2020609440.27761684633918Ilp2FBgn00360460.7609271940.09398943939150Insulin-like peptide 2Ilp3FBgn00440500.9585270520.69113422439151Insulin-like peptide 3Ilp5FBgn0044048not in the datasetnot in the dataset2768992Insulin-like peptide 5CbsFBgn0031148**0.0002785350.000174874**33081Cystathionine beta-synthaseCG5389FBgn00365680.3188683090.17706720439761CG4389FBgn0028479**0.0017578497.90528E-05**34276CG4389 gene product from transcript CG4389-RACG7834FBgn00396970.2193464440.11176124543515CG7834 gene product from transcript CG7834-RArprFBgn00117060.4284758520.08134098440015reaperAkhFBgn0004552**2.04158E-06**0.08810508138495Adipokinetic hormone

Author response table 2.The table was downloaded from the GenAge database and shows *D. melanogaster* genes whose homologs affect *C. elegans* and *S. cerevisiae* lifespans. We asked if gene expression differences as function of age were significant for these genes. We find that there is a good correlation as indicated by significant age-associated p values (highlighted cells).entrez_idgene_idmodel organism frommodel organism gene symbolmodel organism gene entrez_idage-assoc p val. (Control diet)age-assoc p val. (DR diet)37068FBgn0001222*Caenorhabditis elegans*hsf-11730780.208232323**0.014228222**32780FBgn0003380*Caenorhabditis elegans*shk-1174536**0.004195376**0.05899931233379FBgn0003557*Caenorhabditis elegans*wwp-11716470.1422173520.13063464942549FBgn0013984*Caenorhabditis elegans*daf-21754100.349618864**0.011412462**42446FBgn0015279*Caenorhabditis elegans*age-11747620.664739688**1.19E-05**43856FBgn0015624*Caenorhabditis elegans*cbp-11763800.335702205**0.000305516**33025FBgn0015789*Caenorhabditis elegans*rab-10266836**2.50E-050.002107404**37546FBgn0020307*Caenorhabditis elegans*dve-11803980.951050741**0.022711332**47396FBgn0021796*Caenorhabditis elegans*let-363172167**0.0114554990.030110581**43904FBgn0023169*Caenorhabditis elegans*aak-21817270.4435647810.23011177837035FBgn0026316*Caenorhabditis elegans*ubc-181759850.3876128790.45876604444007FBgn0029502*Caenorhabditis elegans*clk-11757290.604169327**4.28E-05**31443FBgn0029752*Caenorhabditis elegans*trx-11818630.4343623980.3027816132864FBgn0030954*Caenorhabditis elegans*ckr-11887740.8398284860.06713543732864FBgn0030954*Caenorhabditis elegans*ckr-21753410.8398284860.06713543737141FBgn0034366*Caenorhabditis elegans*atg-71780050.5218779610.16231649942358FBgn0038736*Caenorhabditis elegans*ire-1174305**0.0047397532.99E-05**117332FBgn0041191*Caenorhabditis elegans*rheb-1176327**2.57E-100.002436925**42162FBgn0003499*Saccharomyces cerevisiae*MSN48538030.3021405880.09295291141311FBgn0011768*Saccharomyces cerevisiae*SFA18513860.161108282**0.021733851**33418FBgn0014010*Saccharomyces cerevisiae*VPS218542560.364851406**0.001462461**42036FBgn0015230*Saccharomyces cerevisiae*HXT178558090.8788177360.47048010942841FBgn0015795*Saccharomyces cerevisiae*YPT78550120.140249034**0.00372342**38565FBgn0015805*Saccharomyces cerevisiae*RPD38553860.4818105470.21601182638654FBgn0015806*Saccharomyces cerevisiae*SCH98566120.6979579820.72579641247396FBgn0021796*Saccharomyces cerevisiae*TOR1853529**0.0114554990.030110581**47611FBgn0022160*Saccharomyces cerevisiae*GUT2854651**0.0232002040.021014678**45706FBgn0023541*Saccharomyces cerevisiae*ERG5855029**0.0050584120.003531191**44098FBgn0024194*Saccharomyces cerevisiae*GUP1852796**0.0001644070.004031428**31410FBgn0025679*Saccharomyces cerevisiae*MSN28550530.3239272210.69418306632768FBgn0030876*Saccharomyces cerevisiae*SRX1853776**3.16E-05**0.27979969533626FBgn0031589*Saccharomyces cerevisiae*NPT18543840.0686251750.48513759733837FBgn0031759*Saccharomyces cerevisiae*GIS18516700.6559293530.16358505934021FBgn0031912*Saccharomyces cerevisiae*LAT18556530.057376425**5.00E-07**37581FBgn0034744*Saccharomyces cerevisiae*VPS20855101**0.0323238856.08E-05**38612FBgn0035600*Saccharomyces cerevisiae*CYT18542310.082518654**1.92E-08**38735FBgn0035704*Saccharomyces cerevisiae*VPS88512610.4096958120.1046757241071FBgn0037647*Saccharomyces cerevisiae*GTR18549180.440417904**0.031441517**41210FBgn0037761*Saccharomyces cerevisiae*SUR48510870.121178495**0.047327998**42185FBgn0038587*Saccharomyces cerevisiae*MDH18537770.201852989**0.005025531**53578FBgn0040309*Saccharomyces cerevisiae*TSA18549800.831741497**0.000946166**53581FBgn0040319*Saccharomyces cerevisiae*GSH18533440.3565150360.17451735438753FBgn0041194*Saccharomyces cerevisiae*ADE4855346**8.21E-062.59E-07**43191FBgn0042710*Saccharomyces cerevisiae*HXK28526390.367984828**0.002632023**42348FBgn0051216*Saccharomyces cerevisiae*PNC1852846**0.052873779**0.09505664332097FBgn0052666*Saccharomyces cerevisiae*PKH28540530.2045558820.40882749442850\#N/A*Caenorhabditis elegans*bec-1177345not in the datasetnot in the dataset40633\#N/A*Caenorhabditis elegans*egl-9179461not in the datasetnot in the dataset41612\#N/A*Caenorhabditis elegans*hif-1180359not in the datasetnot in the dataset48552\#N/A*Caenorhabditis elegans*sams-1181370not in the datasetnot in the dataset41675\#N/A*Caenorhabditis elegans*smk-1179243not in the datasetnot in the dataset39454\#N/A*Caenorhabditis elegans*unc-51180311not in the datasetnot in the dataset37733\#N/A*Caenorhabditis elegans*vps-34172280not in the datasetnot in the dataset31618\#N/A*Saccharomyces cerevisiae*CDC25851019not in the datasetnot in the dataset44297\#N/A*Saccharomyces cerevisiae*DAP2856423not in the datasetnot in the dataset35494\#N/A*Saccharomyces cerevisiae*FET3855080not in the datasetnot in the dataset3771854\#N/A*Saccharomyces cerevisiae*HHF1852294not in the datasetnot in the dataset42414\#N/A*Saccharomyces cerevisiae*HST2856092not in the datasetnot in the dataset326219\#N/A*Saccharomyces cerevisiae*LCB4854342not in the datasetnot in the dataset318252\#N/A*Saccharomyces cerevisiae*NFU1853826not in the datasetnot in the dataset35988\#N/A*Saccharomyces cerevisiae*RPL31A851484not in the datasetnot in the dataset42850\#N/A*Saccharomyces cerevisiae*VPS30855983not in the datasetnot in the dataset

*Lastly, the authors write: "only a small fraction of metabolites showed more than 2-fold changes between the two diets"; are these given in the supplementary material? In fact, is the full data available as supplementary material or in a suitable repository*?

We included a figure ([Figure 3C](#fig3){ref-type="fig"}) with two separate heatmaps to show age-associated trends for metabolites with greater or less than 2-fold changes between the two diets. In that panel, the number of metabolites contributing to each heatmap is provided on the left. We also provide the entire dataset in Supplementary Materials. The data is presented in a user-friendly format featuring peak intensities for each metabolite across all time points for both diets. This file contains directions for normalization (including loaded controls), aside from description in Methods. The full dataset also features retention times, m/z values and identity of structurally resolved metabolites for further investigation.

*Overall, this is an original and interesting work, though some aspects of the manuscript may be improved and clarified. It is possible that some of my comments reflect misunderstandings of mine. If so then I would suggest that the author uses my misunderstandings as an indication that such points might be made clearer in the manuscript*.

*It my usual policy to reveal my identity to the authors: Joao Pedro de Magalhaes*.

We sincerely appreciate these insightful comments.

Reviewer 2:

*Avanesov et al. describe a metabolome analysis of fruit fly aging, using both a standard and lifespan extending restricted diet. They find that 15 % of metabolites levels change during aging; that the timing and speed of metabolite level changes during aging largely parallels those of mRNA, and is slower under lifespan extending dietary conditions; that the number of detected metabolites increases with age; that metabolites in the lipid fraction decrease with age and that this decrease is unrelated to diet effect/longevity. Also, interestingly, the rate of metabolome changes is decelerated during aging, though such deceleration is not observed in gene expression (although the latter data is from another experiment). The authors further find higher levels of potentially damage-representing metabolites in long-lived DR flies, than standard diet fed flies, which they suggest could be explained by extra stress resistance of DR flies*.

*Major points*:

*The data and the methods appear sound. My main objection is regarding how some results were interpreted. For me, the claims that metabolome changes are directly linked to mortality, and that metabolome changes reflect cumulative damage, are both overinterpretations. Specifically*:

*1) "This transition in the metabolome diversity corresponded to the late-life transition in the survival curves, linking metabolome diversity with the aging process. Thus, while damage accumulation is continuous throughout adulthood, it decelerates at advanced stages of life.*"

*For me, this does not link "metabolome diversity with the aging process", but only suggests a link*.

We have modified the original expression to "suggest", referring to the relationship between changes in metabolite diversity and aging. We clarify on why diversity represents damage below.

*Second, how is it concluded that metabolome diversity reflects damage accumulation? This should be better explained, or the claim softened*.

We offer additional explanation in the revised version and add new analyses ([Figure 1B,C](#fig1){ref-type="fig"} and [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}) which strengthen our interpretations. A similar point was made by Reviewer 1 (please see responses to Comment 3).

*2) "The observed changes in the metabolome uncovered a link between the aging process and metabolite diversity. They also suggested that many metabolites reaching detection in the course of aging may represent low levels of by-products or other damage forms.*"

*Again, based on what*?

As can be seen in the revised version ([Figure 1B, C](#fig1){ref-type="fig"}) metabolites that registered at zero at least in one sample, when detected in remaining samples have peak intensities at few orders of magnitude lower compared to 205 known metabolites that were used as comparison markers. Thus, we think that these untargeted species (increasing in diversity) may also represent by-products of metabolism, for example, via enzymatic promiscuity.

*3) "The observed pattern provided additional insights into damage accumulation. For example, the number of newly detected species did not rise exponentially or linearly during aging, instead reflecting deceleration of aging in late life.*"

*Again, this only assuming that the change in metabolite number reflects damage accumulation*.

Our additional data provide support for the notion that the rise in the number of detected molecules represents damage, or at least the majority of it. These molecules are not random and present in diverse dietary regimens (yeast complete and DR-like defined medium). Unlike systemic changes that are bi-directional (increases and decreases) we observe a very negligible decrease in metabolite diversity and instead see a strong and prominent increase ([Figure 1B](#fig1){ref-type="fig"}). This would be analogous to the age-associated rise in DNA mutations, except in our case we cover a much larger repertoire of molecular targets. This allows us to monitor the rate of cumulative damage, and this is more accurate that using limited set of damage markers reported in previous studies.

*4) "This data is also congruent with the damage pattern (*[*Figure 1B,C*](#fig1){ref-type="fig"}*) and confirms the links between activity-dependent damage accumulation and aging.*"

In the revision, we have revised this statement by replacing "confirms" with "suggests".

*5) "This pattern matched transitions in the mortality curves (\...)"*.

*In order to claim this, the authors should first clearly define "transitions in the mortality curves"; i.e., the ages when transitions happen. They could then show that points when metabolite number changes or metabolite intensity level changes decelerate or accelerated correspond to these mortality transitions*.

We removed matched and replaced it with corresponds. We also attempted to illustrate transitions more clearly using a newly added [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} serving as a support to the main [Figure 1](#fig1){ref-type="fig"}. This additional figure reveals better correlations and transitions after we superimpose changes in metabolite diversity and changes in mortality (the number of dead flies). .

*In summary, the general claim here is that because the change in metabolite number is correlated with mortality, the former should reflect molecular damage. This involves a lot of assumptions (which are not openly stated) and can only be a suggestion, not an observation*.

Our claim that metabolite diversity represents damage is better supported by the actual data on diversity which we explained in several places below and provided additional evidence for its support in [Figure 1B,C](#fig1){ref-type="fig"}. Correlations with mortality were supportive since the rate of damage (as represented by changes in metabolite diversity) declined along with mortality ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}).

*Second, I am not sure if the mortality curves indeed are correlated with the change in detected metabolite number. In* [*Figure 1B-C*](#fig1){ref-type="fig"}*, the increase in metabolite diversity appears before mortality increases, it slows down when mortality increases. So I am not sure whether it could be concluded that deceleration in metabolite diversity refletcs "deceleration of aging in late life"*.

[Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} in the revised manuscript better reveals a correlation between transition points of mortality and metabolome diversity curves. We suggest that deceleration of aging is reflected in reduced metabolic activity (bottom panel of [Figure 5D](#fig5){ref-type="fig"}), which leads to reduced metabolite diversity.

[^1]: These authors contributed equally to this work.
